The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)

BACKGROUND: The Glivec International Patient Assistance Program (GIPAP) is a unique direct-to-patient program that provides imatinib (Glivec) at no cost to eligible patients in low- and middle-income countries (LMICs) with chronic myelogenous leukemia (CML) or gastrointestinal stromal tumor (GIST)....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:EClinicalMedicine
Egile Nagusiak: Umeh, Chukwuemeka A., Garcia-Gonzalez, Pat, Tremblay, David, Laing, Richard
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2020
Gaiak:
Research paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046500/
https://ncbi.nlm.nih.gov/pubmed/32140674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2020.100257
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak